111 related articles for article (PubMed ID: 12415784)
21. [Regional hyperthermic perfusion--therapeutic concept and long term results].
Göhl J; Hohenberger W
Langenbecks Arch Chir Suppl Kongressbd; 1992; ():494-501. PubMed ID: 1493314
[TBL] [Abstract][Full Text] [Related]
22. Isolated hepatic perfusion for metastatic melanoma.
Yamamoto M; Zager JS
J Surg Oncol; 2014 Mar; 109(4):383-8. PubMed ID: 24166748
[TBL] [Abstract][Full Text] [Related]
23. Regional chemotherapy by isolation-perfusion.
McBride CM; McMurtrey MJ; Copeland EM; Hickey RC
Int Adv Surg Oncol; 1978; 1():1-9. PubMed ID: 553035
[TBL] [Abstract][Full Text] [Related]
24. Pelvic perfusion for locally recurrent unresectable rectal tumors.
Unal AE; Bayar S; Tez M; Gocmen E; Kocaoglu H; Akgul H
Hepatogastroenterology; 2005; 52(63):757-60. PubMed ID: 15966199
[TBL] [Abstract][Full Text] [Related]
25. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].
Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; Calabrò F; Campaldini B; Colaluca P; Molino A; Cetto GL
Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492
[TBL] [Abstract][Full Text] [Related]
26. [Amrubicin].
Shimizu T; Takada M; Yana T; Fukuoka M
Nihon Rinsho; 2002 May; 60 Suppl 5():374-7. PubMed ID: 12101692
[No Abstract] [Full Text] [Related]
27. Palliation of skeletal melanoma metastases with isolated limb perfusion chemotherapy.
Rajpar SF; Martin-Clavijo A; Marsden JR; Byrne D
Dermatol Surg; 2006 Sep; 32(9):1199-201. PubMed ID: 16970706
[No Abstract] [Full Text] [Related]
28. Percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma.
Maruo T; Motoyama S; Hamana S; Yoshida S; Ohara N; Yamasaki M; Ku Y
Surg Oncol Clin N Am; 2008 Oct; 17(4):843-56, x. PubMed ID: 18722922
[TBL] [Abstract][Full Text] [Related]
29. Isolated lung perfusion for pulmonary metastases.
Hendriks JM; Van Putte BP; Grootenboers M; Van Boven WJ; Schramel F; Van Schil PE
Thorac Surg Clin; 2006 May; 16(2):185-98, vii. PubMed ID: 16805207
[TBL] [Abstract][Full Text] [Related]
30. Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.
van Iersel LB; de Leede EM; Vahrmeijer AL; Tijl FG; den Hartigh J; Kuppen PJ; Hartgrink HH; Gelderblom H; Nortier JW; Tollenaar RA; van de Velde CJ
Eur J Surg Oncol; 2014 Nov; 40(11):1557-63. PubMed ID: 25125340
[TBL] [Abstract][Full Text] [Related]
31. Future directions in regional treatment strategies for melanoma and sarcoma.
Beasley GM; Ross MI; Tyler DS
Int J Hyperthermia; 2008 May; 24(3):301-9. PubMed ID: 18393007
[TBL] [Abstract][Full Text] [Related]
32. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
de Gramont A; Van Cutsem E
Oncology; 2005; 69 Suppl 3():46-56. PubMed ID: 16301835
[TBL] [Abstract][Full Text] [Related]
33. Loco-regional perfusions (stop-flow techniques): state of art and future.
Guadagni S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):119-22. PubMed ID: 16767917
[TBL] [Abstract][Full Text] [Related]
34. Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.
Deroose JP; Eggermont AM; van Geel AN; Verhoef C
Curr Opin Oncol; 2011 Mar; 23(2):183-8. PubMed ID: 21150602
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience with the HER1/EGFR tyrosine kinase inhibitor erlotinib.
Sandler A
Oncology (Williston Park); 2003 Nov; 17(11 Suppl 12):17-22. PubMed ID: 14682119
[TBL] [Abstract][Full Text] [Related]
36. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
[TBL] [Abstract][Full Text] [Related]
37. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
[TBL] [Abstract][Full Text] [Related]
38. Isolated pelvic perfusion in irradiated unresectable recurrence of pelvic tumor: preliminary outcome and ongoing study.
Uzan C; Goere D; Dumont F; Gouy S; Muret J; Hakime A; De Baere T; Bonvalot S
J Visc Surg; 2014 Apr; 151 Suppl 1():S11-5. PubMed ID: 24582274
[TBL] [Abstract][Full Text] [Related]
39. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
40. Palliation for pelvic carcinoma. A study of isolated pelvic perfusion with chemotherapeutic agents.
Swaney RN; Pace WG
Ohio State Med J; 1966 Aug; 62(8):795-7. PubMed ID: 5946211
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
